TNF and atrial fibrillation: Pioglitazone suppresses the expression of transforming growth factor-β1 (TGF-β1) and tumor necrosis factor-α (TNF-α) in atrial tissue, molecules that are mediators of inflammation related to the incidence of AF mediated by fibrosis [85].